Thank you for visiting our website

Dualsystems Biotech AG is a biotech company and we are specialise in providing services to elucidate protein-protein interaction.

You will find here some more information about our new product LRC – Ligand receptor capture.

TriCEPS-based ligand-receptor capture is a novel technology. LRC-TriCEPS enables the unbiased identification of cell surface receptors and off-targets on the living cells without genetic manipulation. Ligand-receptor capture technology can be used for many types of orphan ligands, such as peptides, proteins, antibodies, engineered affinity binders but also for viruses.

Now available: The next generation of LCR-TriCEPS

Video – how the LRC-TriCEPS technology works

Orphan ligands:

  • Extracellular proteins
  • Peptide ligands
  • Antibodies
  • Engineered affinity binders
  • Viruses


  • BioMed
  • Follicum
  • Igenica Biotherapeutics
  • QIMR Berghofer
  • University of Miami
  • Münster University Hospital
  • University of Manitoba
  • The Rockefeller University
  • Medizinische Hochschule Hannover
  • Igenica Biotherapeutics (USA)
  • University of California San Francisco (UCSF)
  • CEDOC – Centro de Estudos de Doenças Crónicas
  • Washington University School of Medicine

For more information visit the LRC-TriCEPS Service page

Ligand-receptor capture LRC-TriCEPS Flyer